Abivax Sa ADR
(ABVX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 06-2023 | 12-2022 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 272,677 | 124,721 | 28,395 |
| Marketable Securities | 9,942 | N/A | 0 |
| Receivables | 26,890 | 17,434 | 9,726 |
| Other current assets | -1 | 0 | -1 |
| TOTAL | $309,508 | $142,155 | $38,120 |
| Non-Current Assets | |||
| PPE Net | 2,561 | 2,749 | 2,529 |
| Investments And Advances | 13,929 | 14,549 | 12,336 |
| Other Non-Current Assets | 29,593 | 28,304 | 27,460 |
| TOTAL | $46,083 | $45,602 | $42,325 |
| Total Assets | $353,979 | $186,547 | $79,593 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 11,480 | 10,529 | 11,276 |
| Accounts payable and accrued liabilities | 51,107 | 32,105 | 16,304 |
| Accrued Expenses | 6,573 | 4,339 | 2,423 |
| Other current liabilities | 6,645 | 3,416 | 3,850 |
| TOTAL | $75,806 | $50,388 | $33,854 |
| Non-Current Liabilities | |||
| Long Term Debt | 2,774 | 5,526 | 9,616 |
| Other Non-Current Liabilities | 63,255 | 42,867 | 28,549 |
| TOTAL | $66,029 | $48,393 | $38,165 |
| Total Liabilities | $141,835 | $98,782 | $72,019 |
| Shareholders' Equity | |||
| Common Shares | 681 | 463 | 235 |
| Retained earnings | -306,236 | -56,650 | -63,996 |
| Other shareholders' equity | 122 | -156,326 | -87,207 |
| TOTAL | $212,142 | $87,765 | $7,574 |
| Total Liabilities And Equity | $353,977 | $186,547 | $79,593 |